EGCG inhibits hypertrophic scar formation in a rabbit ear model
Journal of Cosmetic Dermatology · 2023
DOI: 10.1111/jocd.15587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Yajuan Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Cicatrix, Hypertrophic, Catechin. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation of National Natural Science Foundation of China, Shaanxi Provincial Science Foundation.
Abstract (Originalsprache)
Objective
Hypertrophic scarring is a common skin fibro‐proliferative disease, but currently there has no satisfactory drugs for anti‐scar treatments. Previous study showed that epigallocatechin gallate (EGCG), the main catechin in green tea, improved wound healing and tissue fibrosis in both rats and mice. In the present study, the therapeutic effects of EGCG on hypertrophic scar were analyzed using a rabbit ear hypertrophic scar model. Materials A rabbit ear model of hypertrophic scarring was used. DMSO, 0.5 mg EGCG/wound, 1.0 mg EGCG/wound or triamcinolone were injected subcutaneously once a week for 4 weeks. The scar elevation index (SEI) was measured using HE staining images, the collagen fibers were examined by Masson’ trichrome staining images, and the number of capillaries in hypertrophic scar were calculated by CD31 staining images. The mRNA levels in the scar tissues were detected by quantitative real‐time polymerase chain reaction (qRT‐PCR).
Results
Gross observation and histological evaluation showed the inhibitory effects of EGCG on hypertrophic scar formation at both doses, and decreased scar height and SEI were detected. EGCG also attenuated the mean collagen area fraction and decreased the number of capillaries in scar tissues. qRT‐PCR revealed that EGCG significantly inhibited the mRNA expression of TGF‐β1, Col I, Col III, α‐SMA, and eNOS.
Conclusion
EGCG may serve as a useful candidate therapeutic drug for hypertrophic scar via inhibiting fibrotic gene expression and suppressing angiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
ORCID-Profile: Yajuan Song, Tong Wang, Liu Yang, Junzheng Wu, Lin Chen, Xiao Fan, Zhe Zhang, Qing Yang, Zhou Yu, Baoqiang Song
Förderung
- Foundation of National Natural Science Foundation of China
- Shaanxi Provincial Science Foundation
Zitieren
APA
Song, Y., Wang, T., Yang, L., Wu, J., Chen, L., Fan, X., Zhang, Z., Yang, Q., Yu, Z., & Song, B. (2023). EGCG inhibits hypertrophic scar formation in a rabbit ear model. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15587
Vancouver
Song Y, Wang T, Yang L, Wu J, Chen L, Fan X, et al. EGCG inhibits hypertrophic scar formation in a rabbit ear model. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15587
BibTeX
@article{Song2023,
author = {Song, Yajuan and Wang, Tong and Yang, Liu and Wu, Junzheng and Chen, Lin and Fan, Xiao and Zhang, Zhe and Yang, Qing and Yu, Zhou and Song, Baoqiang},
title = {EGCG inhibits hypertrophic scar formation in a rabbit ear model},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
doi = {10.1111/jocd.15587}
}
EUVIMED